Who do you rate?
Recommend a Supplier
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
Download the case study today and access proven strategies for faster, safer technology transfer.
Brought to you by Suanfarma, this case study highlights how risk-based methodologies can transform technology transfer and scale-up in CDMOs. By applying structured approaches, companies can save months of time and millions in cost, while ensuring scalability, compliance, and stronger partnerships.
Why read this case study?
Technology transfer and scale-up are critical moments in drug development. This case study demonstrates how a risk-based approach delivered measurable improvements in CDMO projects — from small molecule synthesis to fermentation-based processes.
You’ll learn how to:
Suanfarma is a global pharmaceutical group and CDMO with over 25 years of experience in the development, manufacture, and commercialisation of active pharmaceutical ingredients (APIs). With a strong international presence and commitment to innovation, Suanfarma supports pharma and biotech companies worldwide through advanced capabilities, regulatory expertise, and sustainable manufacturing solutions.
Download the Tech Transfer Case Studies by Suanfarma
Help us find the most innovative and trusted suppliers in Pharma and Biotech.